Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
Feb 6, 2014

Mass Spec Sample Prep and Multiplexing Trends

A number of methodologies are being developed that you need to watch.

Mass Spec Sample Prep and Multiplexing Trends

Multiplexed mass spec is being used as a way to detect multiple analytes simultaneously. [© auremar - Fotolia.com]

  • The focus of this GEN Market & Tech Analysis report is our continuing coverage of the mass spectrometry space as it's translating from research to clinic, the third report in a series focused on mass spectrometry and its clinical deployment that also includes "Mass Spec Market Snapshot" and "Laboratory-Developed Tests Based on Mass Spec". Highlights:

    • Overall theme: trends in sample preparation and multiplexing in mass spectrometry.
    • As mass spectrometry translates from research to clinic, a number of methodologies for front-end sample preparation are being developed. This report provides a snapshot of these efforts.
    • Multiplexed mass spectrometry as a means to detect multiple analytes simultaneously is a space which we continue to characterize—presented here are some methodologies that are being developed with an emphasis towards clinical utilization (for example, for the detection of pathogens).
    • These efforts en bloc suggest a definite translation of this discipline toward the clinic.


Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »